about
No inequalities in survival from colorectal cancer by education and socioeconomic deprivation - a population-based study in the North Region of Portugal, 2000-2002.Prediagnosis lifestyle exposures and survival of gastric cancer patients: a cohort study from Portugal.Minimally Invasive Colorectal Cancer Surgery in Europe: Implementation and Outcomes.Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patientsMiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors.False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes.Consistency and inconsistency in testing biomarkers in breast cancer. A GRELL study in cut-off variability in the Romance language countries.Trends in gastric and esophageal cancer incidence in northern Portugal (1994-2009) by subsite and histology, and predictions for 2015.Prostate cancer incidence and mortality in Portugal: trends, projections and regional differences.Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015.Incidence of second primary cancers in North Portugal-a population-based study.Cancer incidence predictions in the North of Portugal: keeping population-based cancer registration up to date.Evaluation of the frequency of and survival from second primary cancers in North Portugal: a population-based study.Clinicopathological differences between interval and screen-detected breast cancers diagnosed within a screening programme in Northern Portugal.Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder.Mammographic screening programmes in Europe: organization, coverage and participation.Western long-term accuracy of serum pepsinogen-based gastric cancer screening.Neovascularisation is a prognostic factor of early recurrence in T1/G2 urothelial bladder tumours.Performance indicators evaluation of the population-based breast cancer screening programme in Northern Portugal using the European Guidelines.Cancer incidence and survival (1997-2006) among adolescents and young adults in the north of Portugal.Incidence rates and trends of lip, oral and oro-pharyngeal cancers in Portugal.Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families.Assessing the completeness of cancer registration using suboptimal death certificate informationHealth-related behaviours in the EpiPorto studySerum pepsinogen test for early detection of gastric cancer in a European CountryGrade is an independent prognostic factor for feline mammary carcinomas: A clinicopathological and survival analysisDNA content in malignant salivary gland tumoursValidation of a Consciousness Level Scale for Palliative CareKi-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification
P50
Q36096370-DA2DEBC2-6078-4529-81C9-9C35D395426DQ36117158-E11EF722-43D8-4523-986A-9547D256C5C7Q36988808-DDE35680-BADD-48B6-B957-9BE18A33C13DQ37135262-B64F6C49-0FAC-4EDA-BB1F-818D23118D65Q37615759-F3ADFD22-61C8-4DFC-A1FE-5B0884022FA6Q38042899-19AA19DC-3147-4D9E-8063-0D4C5252C17FQ38426380-ACAEC1FD-7DA5-438E-B733-0450201F7A86Q38803748-A25AA23B-765E-4420-B1AF-8498837F38A2Q38835325-A4DD5F59-BA81-4375-96F8-6C5EE2A26806Q39364248-6D012E0C-8F27-45FF-B36C-B12E44EE94B9Q40753948-D3020B8E-CDBD-42AC-8F97-215411078C01Q41443058-4579841C-20C1-4AF8-AB1E-3224D985F613Q43825719-5987AD28-8A71-42E1-B9F2-5CDD219B7B36Q44089144-DEB86F4B-A09F-44E4-A908-AEAB95467498Q44297255-3FF0F31A-37D2-4B26-BF3C-49C67E3BD93AQ45328273-6B509B7C-1ECE-48A2-9156-5D4AE5FC8C69Q50034648-75EB0CDD-5295-47D9-9600-32CEE925F722Q51018904-A28AD351-27B8-4F35-B071-C51486FCBE95Q51084296-0D542498-D525-4874-8A05-950FFD09A764Q51192351-41FA8AEA-B5BC-409C-AD4E-2FEED8DE2EA2Q51306169-485CD9E1-372A-4C5E-8E1F-F9AEDCE59328Q51752782-6C1DA94C-599F-4424-A7E5-6F52A2D92F38Q51796578-3AE85B9F-3FBA-4474-9915-0D4A9511A107Q58873464-C19497F6-B73A-4166-9D2C-C1C54E2C0E00Q58873492-96256E6A-9D18-4BBD-A4A1-3410E77E66F2Q61022906-4174EAB1-73B1-41D5-8AF0-8D8EDEAF24BDQ61022912-463F153E-2E40-4573-A2F1-90C7833586C9Q61022914-ACBADBE0-8396-4286-8A78-9E274AE30CE8Q61022915-C39486C9-9A27-4388-999C-C8745AFF5266Q61022916-1C6A3BBC-75B8-4BF2-A103-A1D632519072
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria José Bento
@ast
Maria José Bento
@en
Maria José Bento
@es
Maria José Bento
@nl
Maria José Bento
@sl
type
label
Maria José Bento
@ast
Maria José Bento
@en
Maria José Bento
@es
Maria José Bento
@nl
Maria José Bento
@sl
prefLabel
Maria José Bento
@ast
Maria José Bento
@en
Maria José Bento
@es
Maria José Bento
@nl
Maria José Bento
@sl
P106
P21
P31
P496
0000-0002-7690-9830